One of our experts, Professor David Heal, will be giving a presentation “Psychedelics and CNS Drugs with Novel Mechanisms. Non-clinical Abuse Evaluations to Meet the Challenge” during a Continuing Education course associated with the Safety Pharmacology Society Virtual Meeting, 4th to 8th October 2021.

This talk forms part of the CE course ‘CNS Biomarkers of Mood Disorders and Drug Abuse: Where Are We?’ which will take place on Monday 11th October 2021 from 10:00-13:30h EDT (15.00-18.30h BST; 16.00-19.30h CEST).

DevelRx specialises in non-clinical abuse and dependence evaluations of centrally-acting compounds.

 for a copy of our presentation and to find out how we can support the development of your psychedelics and CNS drugs with novel mechanisms.

We invite you to attend our presentation ‘Psychedelics and CNS Drugs with Novel Mechanisms. Non-clinical Abuse Evaluations to Meet the Challenge’ Continuing Education Course, Virtual SPS Meeting, October 2021